Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Amyloidosis × isatuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Immunoglobulin Light-chain Amyloidosis 2 Purpura 1 Nausea 1 Macroglossia 1 Lymphadenopathy 1 Hepatomegaly 1 Gastrointestinal Hemorrhage 1 Diarrhea 1 Constipation 1 Amyloidosis 1

Interventions

pomalidomide 1 isatuximab 1 Melphalan 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡